After 95% efficacy, what's next for Pfizer Covid-19 vaccine candidate

The news of the final analysis of the trial’s data came as the Covid-19 pandemic continues to worsen across the world.

from Hindustan Times - world https://bit.ly/373xKVZ
https://ift.tt/2zbki14